Oral Squamous Cell Carcinoma clinical trials

Explore recruiting oral squamous cell carcinoma clinical trials.

Recruiting oral squamous cell carcinoma studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Oral Squamous Cell Carcinoma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Fluorescence Intraoperative Surgical Margin Analysis in Head and Neck Cancer: Clinical Validation

Netherlands

Therapeutic confirmatory (Phase III) EU CTIS Study details

NOCANO: Nivolumab as neoadjuvant immunotherapy for patients with Oral CANcer and identification of response-predictive biomarkers in tumour draining lymph NOdes

Sweden

Therapeutic exploratory (Phase II) EU CTIS Study details

An open-label, non-randomized, single center, single dose, exploratory phase II trial of FG001 (an imaging agent) in combination with transoral robotic surgery for oropharyngeal squamous cell carcinoma and neck dissection surgery for oral squamous cell carcinoma with regional lymph node metastases

Denmark

Therapeutic exploratory (Phase II) EU CTIS Study details

Oral Squamous Cell Carcinoma trials by city

Oral Squamous Cell Carcinoma clinical trials

Recruiting oral squamous cell carcinoma studies right now

High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer

A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer

High-Resolution PET-CT Imaging for Surgical Margin Visualization

Postoperative Radiotherapy for Early-stage Oral Tongue Squamous Cell Carcinoma Patients With Risk Factors: a Prospective, Multicenter, Randomized Controlled, Open-labelled Trial

Neoadjuvant Low-Dose Radiotherapy Combined With Adebrelimab and Single-Agent Albumin-Bound Paclitaxel Chemotherapy for Early-Stage Oral Squamous Cell Carcinoma: A Prospective, Single-Arm Clinical Trial

Neoadjuvant Anti-PD-1 Immunotherapy With Chemotherapy in Resectable Locally Advanced Oral Squamous Cell Carcinoma

Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia

Intratumoral Delivery of Viral Replicon (saRNA) Particles Expressing IL-12 in Head and Neck Cancer

Nisin in Oral Cavity Squamous Cell Carcinoma (OCSCC)

A Study on Tumor Budding Guiding Individualized Surgical Planning of Early-stage Oral Squamous Cell Carcinoma.

Preservation of Swallowing in Respected Oral Cavity Squamous Cell Carcinoma: Examining Radiation Volume Effects (PRESERVE): A Randomized Trial

Neoadjuvant Immunochemotherapy for LAOSCC

Also recruiting in Europe

Fluorescence Intraoperative Surgical Margin Analysis in Head and Neck Cancer: Clinical Validation

NOCANO: Nivolumab as neoadjuvant immunotherapy for patients with Oral CANcer and identification of response-predictive biomarkers in tumour draining lymph NOdes

An open-label, non-randomized, single center, single dose, exploratory phase II trial of FG001 (an imaging agent) in combination with transoral robotic surgery for oropharyngeal squamous cell carcinoma and neck dissection surgery for oral squamous cell carcinoma with regional lymph node metastases

Oral Squamous Cell Carcinoma trials by city

Other conditions